Is Now The Time To Invest In Actuate Corp (BIRT), New York & Company, Inc. (NWY), and Clinuvel Pharmaceuticals Ltd (ADR) (CLVLY)?

Posted by admin December 9, 2014 0 Comment 554 views


New York, NY – GDP INSIDER  –  12/09/2014.

This article discusses three companies: Actuate Corp (NASDAQ:BIRT), New York & Company, Inc. (NYSE:NWY), and Clinuvel Pharmaceuticals Ltd (ADR) (OTCMKTS:CLVLY)

Actuate Corp (NASDAQ:BIRT) had a trading volume of 2.98 million yesterday. This figure is 2.56 million higher than the company’s three month average volume of 0.42 million. These numbers indicate that investor interest in Actuate Corp. is on the rise. Despite the high trading volume, the stock had a rather small trading range on Dec. 8th, 2014, as the stock was exchanged for a low price of $6.55 and a high mark of $6.56. In other words, the company’s high trading volume did not affect its stock price.

Is Actuate Corp. Worth An Investment? Learn More About BIRT’s Trajectory With Our Free BIRT Analysis.

New York & Company, Inc. (NYSE:NWY) traded for as little as $2.43 yesterday, a price which represents a new 52 week low for the company. The stock had a trading volume of 0.14 million yesterday, which is 0.06 million lower than its three month average volume of 0.2 million. New York & Company has a beta of 0.87, meaning that the stock is 13% less volatile than the market. The company has an earnings per share (TTM) of $–0.05 and a market capitalization of $156.02 million.

Could New York & Company Hit Rock Bottom? Click Here For A Free NWY Analysis And Get The Edge You Need.

Clinuvel Pharmaceuticals Ltd (ADR) (OTCMKTS:CLVLY) opened at a price of $3.27 after previously closing at a price of $3.60. The stock finished yesterday’s trading at a closing price of $3.30 after an 8.33% loss in value. The stock has traded within a range of $0.90 to $5.00 over the past 52 weeks,  which indicates that Clinuvel Pharmaceuticals Limited is still in relatively good shape. The company has an earnings per share (TTM) of $–0.12 and a market capitalization of $139.89 million.

Should You Invest In Clinuvel Pharmaceuticals Limited? Get A Jump On Wall Street With Our Free CLVLY Analysis.

About HotStockGains

HotStockGains.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.

Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.

Disclosure:  HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.


Write Your Comment